
Publications - Bibliography
J.H. Coggin, Jr., Enhanced
Virus Transformation of Hamster Embryo Cells In Vitro,
J. Virol. 3:458-462 (1969).
Coggin, Jr., J. H., Ambrose, K. R., and Anderson, N.
G. Fetal Antigen Capable of Inducing Transplantation
Immunity Against SV40 Hamster Tumor Cells. J. Immunol. 105:524-526
(1971).
Coggin, Jr., J. H., Ambrose, K. R., Bellomy, B. B. and Anderson, N. G.
Tumor Immunity in Hamster Immunized with Fetal Tissue. J. Immuno.
107:526-533 (1971)
Ambrose, K. R., Anderson, N. G. and Coggin, Jr., J. H. Interruption of
SV40 Oncogenesis with Human Fetal Antigen. Nature 233:194-195 (1971).
Girardi, A. J., Reppucci, P., Dierlam, P., Rutala, W., and Coggin, Jr.,
J. H. Prevention of Simian Virus 40 Tumors by Hamster Fetal Tissue:
Influence of Parity Status of Donor Females on Immunogenicity of Fetal
Tissue and on Immune Cell Cytotoxicity. Proc. Nat'l. Acad. Sci.
70(1):183-186 (1973).
Coggin, Jr., J. H., Ambrose, K. R., Dierlam, P. L., and Anderson, N. G.
Proposed Mechanisms by Which Autochthonous Tumors Escape Immune
Rejection. Cancer Res. 34:2092-2101 (1974).
Coggin, Jr., J. H. and Anderson, N. G. Cancer, Differentiation, and
Embryonic Antigens: Some Central Problems. Adv. Cancer Res. 19:105-165
(1974).
Coggin, Jr., J. H. and Ambrose, K. R. Embryonic and Fetal Determinants
on Virally and Chemically Induced Tumors. In Methods in Cancer Research,
Harris Busch (ed.), 18, pp. 371-389, Academic Press, New York (1979).
Coggin, Jr., J. H. Comparison of SV40 Induced Mouse and Hamster Tumor
Specific Transplantation Antigen. J. Nat'l. Cancer Inst. 63:1029-1034
(1979).
Coggin, Jr., J. H. Induction of Transplantation Resistance with Soluble
Simian Virus 40-induced Hamster Tumor-specific Transplantation Antigen.
Cancer Research. 39:2952-2959 (1979).
Coggin, Jr., J. H., Adkison, L., and Anderson, N. G. Fetal Antigens
Shared as Transplantation Rejection Antigens on Chemically Induced Mouse
and Hamster Sarcomas. Cancer Res. 40:1568-1573 (1980).
Weppner, W. A. and Coggin, Jr., J. H. Virus Induced Cellular Immunity to
Simian Virus 40 Tumor-specific Surface Antigens in Adult Hamsters. J.
Natl. Cancer Inst. 64:757-763 (1980).
Weppner, W. A. and Coggin, Jr., J. H. Antigenic Similarity Between
Plasma Membrane Proteins of Fetal Hamster Cells and Simian Virus 40
Tumor Specific Surface Antigens. Cancer Res. 40:1380-1387 (1980).
Weppner, W. A. and Coggin, Jr., J. H. Regulation of Hamster Lymphocyte
Reactivity to Concanavalin A. Cell. Immunol. 54(1):193-202 (1980).
Coggin, Jr., J.H. Embryonic Antigens in Malignancy and Pregnancy: Common
Denominators in Immune Regulation, 1983 Fetal Antigens and Cancer,
Pittman, London (Ciba Foundation Symposium 96), p. 28-54.
Coggin, Jr., J. H., Gillis, L. D. and Payne, Jr., W. J. Differential
Extraction of Tumor Specific Transplantation Antigen and Embryonic
Antigen from SV40- and Adenovirus 7-Induced Sarcoma Cells of Hamsters
with 1-Butanol and 3-M KCl. J. Natl. Cancer Inst. 72:853-862 (1984).
Payne, W. J. and Coggin, Jr., J. H. Mouse Monoclonal Antibody to
Embryonic Antigen: Development, Cross-reactivity with Rodent and Human
Tumors and Preliminary Polypeptide Characterization. J. Natl. Cancer
Inst. 75(3):115-132 (1985).
Coggin, Jr., J. H. Oncofetal Antigens. Nature 319:428 (1986).
Coggin, Jr., J.H., Rohrer, S.D., Leinbach, E.D., Hester, R.B., Liu,
P.I., and Heath, L.S. Radiation-induced Lymphoblastic
Lymphomas/Leukemias and Sarcomas of Mice Express Conserved, Immunogenic
44 Kilodalton Oncofetal Antigen. Amer. J. Pathol. 130(1):136-146 (1988).
Gussack, G.S., Rohrer, S.D., Hester, R.B., Liu, P.I., and Coggin, Jr.,
J.H. Human Squamous Cell Carcinoma Lines Express Oncofetal 44 kD
Polypeptide Defined by Monoclonal Antibody to Mouse Fetus. Cancer
62:57-64 (1988).
R.B. Hester, S.D. Rohrer, P.I. Liu, and J.H. Coggin, Jr. Differential
expression of class I MHC determinants by lymphoblastic
leukemia/lymphoma cell lines. JNCI 82:1209-1214 (1990).
R.B. Hester and J.H. Coggin, Jr. Tumorigenic sublethal whole-body
X-irradiation of RFM mice enhances cell-mediated cytotoxicity while
transiently depressing T- and B-lymphocytes. Molecular Biotherapy.
1(5):244 (1989).
A.L. Barsoum and J.H. Coggin, Jr. Immunogenicity of a soluble partially
purified oncofetal antigen from murine fibrosarcoma in syngeneic mice.
Journal of Biological Response Modifiers. 8:579-592 (1989).
R.B. Hester, S.D. Rohrer, P.I. Liu, and J.H. Coggin, Jr. Differential
expression of class I MHC determinants by lymphoblastic
leukemia/lymphoma cell lines. JNCI 82:1209-1214 (1990).
Barsoum, A. and Coggin, J., Jr. Isolation and partial characterization
of a soluble oncofetal antigen from murine and human amniotic fluids.
Inter. J. Cancer 48:248-252 (1991).
Rohrer, S., Sarli, R., Barsoum, A., Hester, R., and Coggin, J., Jr.
Expression of 44 Kilodalton Oncofetal Antigen as a Premalignancy Marker
in X Irradiation Induced Murine T-Cell Lymphoma JNCI, 84:602-609 (1992).
Barsoum, A. and Coggin, J., Jr. Isolation and characterization of 200kD
oncofetal antigen from radiation induced murine lymphoma tumors. Int. J.
Biochem. 24, 483-489 (1993).
Coggin, J., Rohrer, S, Hester, R., Barsoum, A., Rashid, H., and Gussack,
G. 44-kD oncofetal transplantation antigen in rodent and human fetal
cells: implications of recrudescence in human and rodent cancers.
Archives of Otolaryngology-Head and Neck Surgery, 119: 1257-1266. 1993
Rohrer, J.W., Rohrer, S.D., Barsoum, A.L. and Coggin, Jr, J.H.
Differential recognition of murine tumor associated oncofetal
transplantation antigen and individually specific tumor transplantion
antigens by syngeneic cloned BALB/c and RFM mouse T cells. J. Immunol.
152: pp755-764 Jan. 15, 1994
Rashid, H-U., Barsoum, A.L., Cao, T. M., and Coggin, Jr., J.H. Isolation
of partial DNA clones encoding a protein which has the characteristics
of a unique oncofetal antigen conserved in rodent and human tumors and
fetus. J.N.C.I. 86, 515-525, 1994
Coggin, J.H. Classification of tumor associated antigens in rodents and
humans. Immunology Today: May, Vol. 15: 246-247, 1994.
Rohrer, J , Culpepper, C , Barsoum, A , and Coggin, J H.
Characterization of RFM mouse T lymphocyte anti-OFA immunity in apparent
tumor free, long term survivors of sub-lethal X-irradiation by limiting
dilution T lymphocyte cloning. J. of Immunology, 154: 2266-2280, 1995.
Coggin, J.H., Jr., Barsoum, A., and Rohrer, J. 1999. Tumors express both
unique TSTA and crossprotective 44KDa oncofetal antigen. Immunol. Today
19: 405-408 [Viewpoint].
Rohrer J. W., A. L. Barsoum, D. L. Dyess, J. A. Tucker and J. H. Coggin,
Jr. Human breast carcinoma patients develop clonable oncofetal
antigen-specific effector and regulatory T lymphocytes. J. Immunol. 162:
6880-6892, 1999.
Coggin J. H., Jr., A. L. Barsoum and J. W. Rohrer. 37 Kilodalton
oncofetal antigen protein and immature laminin receptor protein are
identical, universal T-cell inducing immunogen on primary rodent and
human cancers. Anticancer Res. 19: 5535-5542, 1999.
Barsoum A. L., J. W. Rohrer and J. H. Coggin, Jr. 37kDa oncofetal
antigen is an autoimmunogenic homologue of the 37kDa laminin receptor
precursor. Cellular & Molecular Biology Letters 5: 207-203, 2000.
Rohrer J. W., A. L. Barsoum and J. H. Coggin, Jr. The development of a
new universal tumor rejection antigen expressed on human and rodent
cancers for vaccination and prevention of cancer and in anti-tumor
therapy. Mod. Aspects of Immunobiol. 1, 191-195, 2001.
Zelle-Rieser C., A. L. Barsoum, F. Sallusto, R. Ramoner, J.W. Rohrer,
Lorenz Höltel, G. Bartsch, J. H. Coggin Jr. and M. Thurnher. Expression
and immunogenicity of oncofetal antigen-immature laminin receptor in
human renal cell carcinoma. J. Urol. 165, 1705-1709, 2001.
Coggin J. H., Jr., A. L. Barsoum, J.W. Rohrer, J. A. Tucker, and D. L.
Dyess Materno-fetal immunobiology hypothesis: immature laminin receptor
protein is a primitive, species conserved, universal embryonic T and B
cell immunogen providing both maternal and fetal protection. Mod.
Aspects of Immunobiol. 2 (2) 84-91, 2001.
Höltl L., C. Zelle-Rieser, H. Gander, C. Papesh, R. Ramoner, G. Bartsch,
H. Rogatsch, A. L. Barsoum, Joseph H. Coggin, Jr. and Martin Thurnher.
Immunotherapy of metastatic renal cell carcinoma with tumor
lysate-pulsed autologous dendritic cells. Clin. Cancer Res. 8 (11)
3369-3376, 2002.
Siegel S, A. Wagner, D. Kabelitz, M. Marget, J. Coggin Jr., A. Barsoum,
J. Rohrer, N. Schmitz, and M. Zeis. Induction of cytotoxic T cell
responses against the oncofetal antigen-immature laminin receptor for
the treatment of hematological malignancies. Blood 102, 4416-4423, 2003.
Coggin J. H. Jr, J. W. Rohrer, and A. L. Barsoum. True immunogenicity of
oncofetal antigen/immature laminin receptor protein. Cancer Res. 64,
4685, 2004
Coggin J. H. Jr., A.L. Barsoum, J. W. Rohrer, M. Thurnher and M. Zeis.
Contemporary definitions of tumor specific antigens, immunogens, and
markers as related to the adaptive responses of the cancer-bearing host.
Anticancer Res. 25, 2345-2356, 2005
Coggin J. H. Jr., A. L. Barsoum, J. W. Rohrer, M.Thurnher, M. Zeis and
P.O. Schwarzenberger. Cancer Vaccine Technology Update: The
immunobiology of 37 kDa Oncofetal Antigen/Immature Laminin Receptor
Protein (OFA/iLRP) and RNA, a universal tumor immunogen. Mod. Asp.
Immunobiol. 16, 27-34, 2005.
Rohrer, J. W., A. L. Barsoum, and J. H. Coggin, Jr. 2006. Identification
of oncofetal antigen/immature laminin receptor protein epitopes that
activate BALB/c mouse OFA/iLRP-specific effector and regulatory T cell
clones. J. Immunol. 176:2844.
Siegel, S., A. Wagner, B. Friedrichs, Anneke Wendeler, L. Wendel, D.
Kabelitz, J. Steinmann, A. Barsoum, J. Coggin, J. Rohrer, P. Dreger, N.
Schmitz, and M. Zeis. 2006. Identification of HLA-A*0201-presented T
cell epitopes derived from the oncofetal antigen-immature laminin
receptor protein in patients with hematological malignancies. J.
Immunol. 176:6935.
Adel L. Barsoum, Bainan Liu, James W. Rohrer, Joseph H. Coggin, Jr., J. Allan Tucker, Lewis K. Pannell, Paul O. Schwarzenberger. 2009. Production, safety and antitumor efficacy of recombinant Oncofetal Antigen/immature laminin receptor protein. Biomaterials (2009), doi:10.1016/j.biomaterials.2009.02.022